Applied Biosciences Corp.
APPB · OTC
3/31/2021 | 3/31/2020 | 3/31/2019 | 3/31/2018 | |
|---|---|---|---|---|
| Market Cap | $3 | $110 | $158 | $301 |
| - Cash | $0 | $1 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $3 | $110 | $158 | $301 |
| Revenue | $0 | $1 | $1 | $0 |
| % Growth | -87.7% | 2.3% | 257.9% | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | -358.5% | 39.6% | 26.2% | 21.3% |
| EBITDA | -$1 | -$4 | -$2 | -$2 |
| % Margin | -817.9% | -518.8% | -281.4% | -1,094.4% |
| Net Income | -$1 | -$5 | -$3 | -$2 |
| % Margin | -865.3% | -646.1% | -371.9% | -1,202.8% |
| EPS Diluted | -0.056 | -0.34 | -0.22 | -0.16 |
| % Growth | 83.5% | -54.5% | -37.5% | – |
| Operating Cash Flow | -$1 | -$1 | -$1 | -$1 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$1 | -$1 | -$1 | -$1 |